Code NFAC FAC Global PC TC Description

Total Page:16

File Type:pdf, Size:1020Kb

Code NFAC FAC Global PC TC Description Surgery Service Codes Spreadsheet as of August 1, 2021 Note: Procedure codes and their corresponding descriptions are obtained from the AMA 2020 CPT and HCPCS. Code NFAC FAC Global PC TC Description Fine needle aspiration biopsy, without imaging guidance; each additional lesion (List separately 10004 $40.44 $33.77 - - - in addition to code for primary procedure) 10005 $102.20 $55.83 - - - Fine needle aspiration biopsy, including ultrasound guidance; first lesion Fine needle aspiration biopsy, including ultrasound guidance; each additional lesion (List 10006 $46.41 $38.30 - - - separately in addition to code for primary procedure) 10007 $239.08 $72.71 - - - Fine needle aspiration biopsy, including fluoroscopic guidance; first lesion Fine needle aspiration biopsy, including fluoroscopic guidance; each additional lesion (List 10008 $135.39 $47.57 - - - separately in addition to code for primary procedure) 10009 $379.52 $88.53 - - - Fine needle aspiration biopsy, including CT guidance; first lesion Fine needle aspiration biopsy, including CT guidance; each additional lesion (List separately in 10010 $227.72 $64.25 - - - addition to code for primary procedure) 10011 - - I.C. - - Fine needle aspiration biopsy, including MR guidance; first lesion Fine needle aspiration biopsy, including MR guidance; each additional lesion (List separately in 10012 - - I.C. - - addition to code for primary procedure) 10021 $78.04 $43.26 - - - Fine needle aspiration biopsy, without imaging guidance; first lesion 10030 $500.16 $107.43 - - - Image-guided fluid collection drainage by catheter (eg, abscess, hematoma, seroma, lymphocele, cyst), soft tissue (eg, extremity, abdominal wall, neck), percutaneous 10035 $367.39 $66.54 - - - Placement of soft tissue localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous, including imaging guidance; first lesion Placement of soft tissue localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive 10036 $314.01 $33.74 - - - seeds), percutaneous, including imaging guidance; each additional lesion (List separately in addition to code for primary procedure) Acne surgery (eg, marsupialization, opening or removal of multiple milia, comedones, cysts, 10040 $87.50 $41.70 - - - pustules) Incision and drainage of abscess (eg, carbuncle, suppurative hidradenitis, cutaneous or 10060 $96.12 $79.60 - - - subcutaneous abscess, cyst, furuncle, or paronychia); simple or single 10061 $165.57 $143.55 - - - Incision and drainage of abscess (eg, carbuncle, suppurative hidradenitis, cutaneous or subcutaneous abscess, cyst, furuncle, or paronychia); complicated or multiple 10080 $169.76 $81.65 - - - Incision and drainage of pilonidal cyst; simple 10081 $243.39 $134.99 - - - Incision and drainage of pilonidal cyst; complicated 10120 $121.34 $81.63 - - - Incision and removal of foreign body, subcutaneous tissues; simple 10121 $216.34 $145.91 - - - Incision and removal of foreign body, subcutaneous tissues; complicated 10140 $135.70 $93.96 - - - Incision and drainage of hematoma, seroma or fluid collection 10160 $103.78 $74.80 - - - Puncture aspiration of abscess, hematoma, bulla, or cyst 10180 $203.72 $140.25 - - - Incision and drainage, complex, postoperative wound infection 11000 $44.92 $22.02 - - - Debridement of extensive eczematous or infected skin; up to 10% of body surface 11001 $18.55 $11.01 - - - Debridement of extensive eczematous or infected skin; each additional 10% of the body surface, or part thereof (List separately in addition to code for primary procedure) Debridement of skin, subcutaneous tissue, muscle and fascia for necrotizing soft tissue 11004 - - $448.00 - - infection; external genitalia and perineum Debridement of skin, subcutaneous tissue, muscle and fascia for necrotizing soft tissue 11005 - - $608.93 - - infection; abdominal wall, with or without fascial closure 11006 - - $549.89 - - Debridement of skin, subcutaneous tissue, muscle and fascia for necrotizing soft tissue infection; external genitalia, perineum and abdominal wall, with or without fascial closure Removal of prosthetic material or mesh, abdominal wall for infection (eg, for chronic or 11008 - - $214.07 - - recurrent mesh infection or necrotizing soft tissue infection) (List separately in addition to code for primary procedure) 11010 $379.48 $217.17 - - - Debridement including removal of foreign material at the site of an open fracture and/or an open dislocation (eg, excisional debridement); skin and subcutaneous tissues Debridement including removal of foreign material at the site of an open fracture and/or an 11011 $421.24 $235.45 - - - open dislocation (eg, excisional debridement); skin, subcutaneous tissue, muscle fascia, and muscle Debridement including removal of foreign material at the site of an open fracture and/or an 11012 $537.99 $327.86 - - - open dislocation (eg, excisional debridement); skin, subcutaneous tissue, muscle fascia, muscle, and bone Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm 11042 $100.45 $47.70 - - - or less Page 1 of 147 Surgery Service Codes Spreadsheet as of August 1, 2021 Note: Procedure codes and their corresponding descriptions are obtained from the AMA 2020 CPT and HCPCS. Code NFAC FAC Global PC TC Description Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if 11043 $183.93 $121.03 - - - performed); first 20 sq cm or less Debridement, bone (includes epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if 11044 $246.74 $177.18 - - - performed); first 20 sq cm or less 11045 $32.86 $20.68 - - - Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure) Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if 11046 $58.06 $43.57 - - - performed); each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure) Debridement, bone (includes epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if 11047 $96.31 $76.90 - - - performed); each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure) 11055 $50.60 $12.34 - - - Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); single lesion 11056 $59.41 $17.97 - - - Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 lesions 11057 $65.13 $22.81 - - - Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); more than 4 lesions 11102 $80.33 $30.48 - - - Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); each separate/additional lesion 11103 $42.61 $17.68 - - - (List separately in addition to code for primary procedure) 11104 $101.03 $38.13 - - - Punch biopsy of skin (including simple closure, when performed); single lesion Punch biopsy of skin (including simple closure, when performed); each separate/additional 11105 $48.52 $20.70 - - - lesion (List separately in addition to code for primary procedure) 11106 $122.32 $46.10 - - - Incisional biopsy of skin (eg, wedge) (including simple closure, when performed); single lesion Incisional biopsy of skin (eg, wedge) (including simple closure, when performed); each 11107 $57.58 $24.82 - - - separate/additional lesion (List separately in addition to code for primary procedure) 11200 $70.62 $58.45 - - - Removal of skin tags, multiple fibrocutaneous tags, any area; up to and including 15 lesions Removal of skin tags, multiple fibrocutaneous tags, any area; each additional 10 lesions, or part 11201 $14.51 $12.77 - - - thereof (List separately in addition to code for primary procedure) Shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter 0.5 cm 11300 $80.57 $26.95 - - - or less Shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter 0.6 to 11301 $97.38 $40.86 - - - 1.0 cm Shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter 1.1 to 11302 $112.57 $47.94 - - - 2.0 cm Shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter over 11303 $123.63 $56.39 - - - 2.0 cm Shaving of epidermal or dermal lesion, single lesion, scalp, neck, hands, feet, genitalia; lesion 11305 $84.34 $30.43 - - - diameter 0.5 cm or less Shaving of epidermal or dermal lesion, single lesion, scalp, neck, hands, feet, genitalia; lesion 11306 $98.68 $39.26 - - - diameter 0.6 to 1.0 cm Shaving of epidermal or dermal lesion, single lesion, scalp, neck, hands, feet, genitalia; lesion 11307 $115.10 $50.76 - - - diameter 1.1 to 2.0 cm Shaving of epidermal or dermal lesion, single lesion, scalp, neck, hands, feet, genitalia; lesion 11308 $122.53 $57.03 - - - diameter over 2.0 cm Shaving of epidermal or dermal lesion, single lesion, face, ears, eyelids, nose, lips, mucous 11310 $92.99 $36.47 - - - membrane; lesion diameter 0.5 cm or less Shaving of epidermal or dermal lesion, single lesion, face, ears, eyelids, nose, lips, mucous 11311 $109.84 $49.84 - - - membrane; lesion diameter 0.6 to 1.0 cm Shaving of epidermal or dermal lesion, single lesion, face, ears, eyelids, nose, lips, mucous 11312 $126.94 $59.12 - - - membrane; lesion diameter 1.1 to 2.0 cm Shaving of epidermal or dermal lesion, single lesion, face, ears, eyelids, nose, lips, mucous 11313 $147.81 $76.80 - - - membrane; lesion diameter
Recommended publications
  • Chapter 28 *Lecture Powepoint
    Chapter 28 *Lecture PowePoint The Female Reproductive System *See separate FlexArt PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Introduction • The female reproductive system is more complex than the male system because it serves more purposes – Produces and delivers gametes – Provides nutrition and safe harbor for fetal development – Gives birth – Nourishes infant • Female system is more cyclic, and the hormones are secreted in a more complex sequence than the relatively steady secretion in the male 28-2 Sexual Differentiation • The two sexes indistinguishable for first 8 to 10 weeks of development • Female reproductive tract develops from the paramesonephric ducts – Not because of the positive action of any hormone – Because of the absence of testosterone and müllerian-inhibiting factor (MIF) 28-3 Reproductive Anatomy • Expected Learning Outcomes – Describe the structure of the ovary – Trace the female reproductive tract and describe the gross anatomy and histology of each organ – Identify the ligaments that support the female reproductive organs – Describe the blood supply to the female reproductive tract – Identify the external genitalia of the female – Describe the structure of the nonlactating breast 28-4 Sexual Differentiation • Without testosterone: – Causes mesonephric ducts to degenerate – Genital tubercle becomes the glans clitoris – Urogenital folds become the labia minora – Labioscrotal folds
    [Show full text]
  • Chapter 24 Primary Sex Organs = Gonads Produce Gametes Secrete Hormones That Control Reproduction Secondary Sex Organs = Accessory Structures
    Anatomy Lecture Notes Chapter 24 primary sex organs = gonads produce gametes secrete hormones that control reproduction secondary sex organs = accessory structures Development and Differentiation A. gonads develop from mesoderm starting at week 5 gonadal ridges medial to kidneys germ cells migrate to gonadal ridges from yolk sac at week 7, if an XY embryo secretes SRY protein, the gonadal ridges begin developing into testes with seminiferous tubules the testes secrete androgens, which cause the mesonephric ducts to develop the testes secrete a hormone that causes the paramesonephric ducts to regress by week 8, in any fetus (XX or XY), if SRY protein has not been produced, the gondal ridges begin to develop into ovaries with ovarian follicles the lack of androgens causes the paramesonephric ducts to develop and the mesonephric ducts to regress B. accessory organs develop from embryonic duct systems mesonephric ducts / Wolffian ducts eventually become male accessory organs: epididymis, ductus deferens, ejaculatory duct paramesonephric ducts / Mullerian ducts eventually become female accessory organs: oviducts, uterus, superior vagina C. external genitalia are indeterminate until week 8 male female genital tubercle penis (glans, corpora cavernosa, clitoris (glans, corpora corpus spongiosum) cavernosa), vestibular bulb) urethral folds fuse to form penile urethra labia minora labioscrotal swellings fuse to form scrotum labia majora urogenital sinus urinary bladder, urethra, prostate, urinary bladder, urethra, seminal vesicles, bulbourethral inferior vagina, vestibular glands glands Strong/Fall 2008 Anatomy Lecture Notes Chapter 24 Male A. gonads = testes (singular = testis) located in scrotum 1. outer coverings a. tunica vaginalis =double layer of serous membrane that partially surrounds each testis; (figure 24.29) b.
    [Show full text]
  • Partial Nephrectomy for Renal Cancer: Part I
    REVIEW ARTICLE Partial nephrectomy for renal cancer: Part I BJUIBJU INTERNATIONAL Paul Russo Department of Surgery, Urology Service, and Weill Medical College, Cornell University, Memorial Sloan Kettering Cancer Center, New York, NY, USA INTRODUCTION The Problem of Kidney Cancer Kidney Cancer Is The Third Most Common Genitourinary Tumour With 57 760 New Cases And 12 980 Deaths Expected In 2009 [1]. There Are Currently Two Distinct Groups Of Patients With Kidney Cancer. The First Consists Of The Symptomatic, Large, Locally Advanced Tumours Often Presenting With Regional Adenopathy, Adrenal Invasion, And Extension Into The Renal Vein Or Inferior Vena Cava. Despite Radical Nephrectomy (Rn) In Conjunction With Regional Lymphadenectomy And Adrenalectomy, Progression To Distant Metastasis And Death From Disease Occurs In ≈30% Of These Patients. For Patients Presenting With Isolated Metastatic Disease, Metastasectomy In Carefully Selected Patients Has Been Associated With Long-term Survival [2]. For Patients With Diffuse Metastatic Disease And An Acceptable Performance Status, Cytoreductive Nephrectomy Might Add Several Additional Months Of Survival, As Opposed To Cytokine Therapy Alone, And Prepare Patients For Integrated Treatment, Now In Neoadjuvant And Adjuvant Clinical Trials, With The New Multitargeted Tyrosine Kinase Inhibitors (Sunitinib, Sorafenib) And Mtor Inhibitors (Temsirolimus, Everolimus) [3,4]. The second groups of patients with kidney overall survival. The explanation for this cancer are those with small renal tumours observation is not clear and could indicate (median tumour size <4 cm, T1a), often that aggressive surgical treatment of small incidentally discovered in asymptomatic renal masses in patients not in imminent patients during danger did not counterbalance a population imaging for of patients with increasingly virulent larger nonspecific abdominal tumours.
    [Show full text]
  • Preoperative Skin Antisepsis with Chlorhexidine Gluconate Versus Povidone-Iodine: a Prospective Analysis of 6959 Consecutive Spinal Surgery Patients
    CLINICAL ARTICLE J Neurosurg Spine 28:209–214, 2018 Preoperative skin antisepsis with chlorhexidine gluconate versus povidone-iodine: a prospective analysis of 6959 consecutive spinal surgery patients George M. Ghobrial, MD, Michael Y. Wang, MD, Barth A. Green, MD, Howard B. Levene, MD, PhD, Glen Manzano, MD, Steven Vanni, DO, DC, Robert M. Starke, MD, MSc, George Jimsheleishvili, MD, Kenneth M. Crandall, MD, Marina Dididze, MD, PhD, and Allan D. Levi, MD, PhD Department of Neurological Surgery and The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, Florida OBJECTIVE The aim of this study was to determine the efficacy of 2 common preoperative surgical skin antiseptic agents, ChloraPrep and Betadine, in the reduction of postoperative surgical site infection (SSI) in spinal surgery proce- dures. METHODS Two preoperative surgical skin antiseptic agents—ChloraPrep (2% chlorhexidine gluconate and 70% iso- propyl alcohol) and Betadine (7.5% povidone-iodine solution)—were prospectively compared across 2 consecutive time periods for all consecutive adult neurosurgical spine patients. The primary end point was the incidence of SSI. RESULTS A total of 6959 consecutive spinal surgery patients were identified from July 1, 2011, through August 31, 2015, with 4495 (64.6%) and 2464 (35.4%) patients treated at facilities 1 and 2, respectively. Sixty-nine (0.992%) SSIs were observed. There was no significant difference in the incidence of infection between patients prepared with Beta- dine (33 [1.036%] of 3185) and those prepared with ChloraPrep (36 [0.954%] of 3774; p = 0.728). Neither was there a significant difference in the incidence of infection in the patients treated at facility 1 (52 [1.157%] of 4495) versus facility 2 (17 [0.690%] of 2464; p = 0.06).
    [Show full text]
  • Incision & Drainage Informed Consent
    Jeri Shuster, M.D., P.A. and Women’s Center, Inc. JERI SHUSTER, M.D., PA & WOMEN’SJeri Shuster, CENTER, INC M.D.,. P.A. Jeri Shuster, M.D., Fellowand of the Women’s American CollegeCenter, Obstetricians Inc. and Gynecologists Kathryn Cervi, C.R.N.P., Women’s Health Care Nurse Practitioner Jeri Shuster, M.D., Fellow of the American College Obstetricians and Gynecologists INFORMED CONSENT: Kathryn INCISION Cervi, C.R.N.P., AND Women’s DRAINAGE Health (I Care & D) Nurse Practitioner I hereby request and authorize Dr. to Jeri Shuster perform upon me the procedure: incision and drainage of _________________________________________________________________________ _____________________________________________________________________________________________ This procedure involves making an incision, either with a scalpel or with an electrical device, in order to enable fluid to drain from an area of the body. The procedure is intended to drain a cyst(s), abscess(es), or infected tissue. Risks include: bleeding, infection, burn injury, pain, scarring, failure to diagnose or cure the underlying condition, persistence or recurrence of the condition. To reduce risk of infection, after the procedure keep area as clean and dry as possible. Wash three times each day with lukewarm water and mild soap. Dry by gently dabbing with a soft wel to or carefully use a blow dryer on the cool setting. Follow each wash/dry with antibacterial ointment (such as Neosporin or Bacitracin). If genital incision and drainage ou is performed, y may also place antibiotic ointment onto cotton balls (not cosmetic puffs) to cover the wounds during urination or bowel movements. Benefits may include achieving a diagnosis (by distinguishing between a cyst and an abscss) and alleviating symptoms such as pain.
    [Show full text]
  • Fearful Symmetries: Essays and Testimonies Around Excision and Circumcision. Rodopi
    Fearful Symmetries Matatu Journal for African Culture and Society ————————————]^——————————— EDITORIAL BOARD Gordon Collier Christine Matzke Frank Schulze–Engler Geoffrey V. Davis Aderemi Raji–Oyelade Chantal Zabus †Ezenwa–Ohaeto TECHNICAL AND CARIBBEAN EDITOR Gordon Collier ———————————— ]^ ——————————— BOARD OF ADVISORS Anne V. Adams (Ithaca NY) Jürgen Martini (Magdeburg, Germany) Eckhard Breitinger (Bayreuth, Germany) Henning Melber (Windhoek, Namibia) Margaret J. Daymond (Durban, South Africa) Amadou Booker Sadji (Dakar, Senegal) Anne Fuchs (Nice, France) Reinhard Sander (San Juan, Puerto Rico) James Gibbs (Bristol, England) John A. Stotesbury (Joensuu, Finland) Johan U. Jacobs (Durban, South Africa) Peter O. Stummer (Munich, Germany) Jürgen Jansen (Aachen, Germany) Ahmed Yerma (Lagos, Nigeria)i — Founding Editor: Holger G. Ehling — ]^ Matatu is a journal on African and African diaspora literatures and societies dedicated to interdisciplinary dialogue between literary and cultural studies, historiography, the social sciences and cultural anthropology. ]^ Matatu is animated by a lively interest in African culture and literature (including the Afro- Caribbean) that moves beyond worn-out clichés of ‘cultural authenticity’ and ‘national liberation’ towards critical exploration of African modernities. The East African public transport vehicle from which Matatu takes its name is both a component and a symbol of these modernities: based on ‘Western’ (these days usually Japanese) technology, it is a vigorously African institution; it is usually
    [Show full text]
  • Loss of Correction in Cubitus Varus Deformity After Osteotomy
    Loss of correction in cubitus varus deformity after osteotomy Chao You Shenzhen children's hospital Yibiao Zhou Shenzhen children's hospital https://orcid.org/0000-0001-9754-1089 Jingming Han ( [email protected] ) Research article Keywords: cubitus varus osteotomy Loss of correction Posted Date: May 5th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-26279/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/14 Abstract Purpose Cubitus varus deformity in the pediatric population is an infrequent but clinically important disease to orthopedic surgeons. Since these patient populations are different in many respects, we sought out to investigate the rates of loss of correction over time as well as the factors associated with loss of correction in pediatric patients undergoing osteotomy for treatment of cubitus varus deformity. Methods Between 2008-7 and 2017-7, we treated 30 cases of cubital varus had underwent the the osteotomy. We compared preoperative and postoperative clinical and imaging parameters (H-cobb angle,Baumman angle) for all patients. Postoperative evaluation was performed by telephone interview. Results In our study,there were 30 patients,included 17 males and 13 females.the mean age was 75 months old.In the rst follow-up,Approximately 80 % of patients had a loss of correction of H-cobband 83% of patients at the second follow-up. The Baumann angle also had a loss of correction,about 57% was lost at the rst follow-up,and 43% was lost at the second follow-up. The average interval between the rst follow-up and the second follow-up was 24 days The H-cobb angle mean loss was 2.4°.There was a statistically signicant difference between the H-cobb angle measured before surgery and the angle measured after surgery (p <0.05).
    [Show full text]
  • 114.3 Cmr: Division of Health Care Finance and Policy Ambulatory Care
    114.3 CMR: DIVISION OF HEALTH CARE FINANCE AND POLICY AMBULATORY CARE 114.3 CMR 40.00: RATES FOR SERVICES UNDER M.G.L. c. 152, WORKERS’ COMPENSATION ACT Section 40.01: General Provisions 40.02: General Definitions 40.03: Service and Rate Coverage Provisions 40.04: Provisions Affecting Eligible Providers 40.05: Policies for Individual Service Types 40.06: Fees 40.07: Appendices 40.08: Severability 40.01: General Provisions (1) Scope, Purpose and Effective Date. 114.3 CMR 40.00 governs the payment rates effective April 1, 2009 for purchasers of health care services under M.G.L. c. 152, the Workers’ Compensation Act. Payment rates for services provided by hospitals are set forth in 114.1 CMR 41.00. Program policies relating to medical necessity and clinical appropriateness are determined pursuant to M.G.L. c. 152 and 452 CMR 6.00. (2) Coverage. The payment rates set forth in 114.3 CMR 40.06 are full payment for services provided under M.G.L. c. 152, § 13, including any related administrative or overhead costs. The insurer, employer and health care service provider may agree upon a different payment rate for any service set forth in the fee schedule in 114.3 CMR 40.00. No employee may be held liable for the payment for health care services determined compensable under M.G.L. c. 152, § 13. (3) Administrative Bulletins. The Division may issue administrative bulletins to clarify substantive provisions of 114.3 CMR 40.00, or to publish procedure code updates and corrections. For coding updates and correction, the bulletin will list: (a) new code numbers for existing codes, with the corresponding cross references between existing and new codes numbers; (b) deleted codes for which there are no corresponding new codes; and (c) codes for entirely new services that require pricing.
    [Show full text]
  • Canadian Surgery Forum Canadien De Chirurgie
    Vol. 44, Suppl., August / août 2001 ISSN 0008-428X ABSTRACTS RÉSUMÉS of presentations to the des communications présentées Annual Meetings of the aux congrès annuels de la Canadian Society of Colon Société canadienne and Rectal Surgeons des chirurgiens du côlon et du rectum Canadian Association of General Surgeons Association canadienne des chirurgiens généraux Canadian Association of Thoracic Surgeons Association canadienne des chirurgiens thoraciques CANADIAN SURGERY FORUM CANADIEN DE CHIRURGIE Québec, QC September 6 to 9, 2001 Québec (QC) du 6 au 9 septembre 2001 Abstracts Résumés Canadian Surgery Forum canadien de chirurgie 2001 Canadian Society of Colon and Rectal Surgeons Société canadienne des chirurgiens du côlon et du rectum 1 2 ARTIFICIAL BOWEL SPHINCTER IMPLANTATION COMPARISON OF DELORME AND ALTEMEIER IN THE MANAGEMENT OF SEVERE FECAL IN- PROCEDURES FOR RECTAL PROLAPSE. E.C. McKe- CONTINENCE — EXPERIENCE FROM A SINGLE vitt, B.J. Sullivan, P.T. Phang. Department of Surgery, St. INSTITUTION. A.R. MacLean, G. Stewart, K. Sabr, M. Paul’s Hospital, University of British Columbia, Vancou- Burnstein. Department of Surgery, St Michael’s Hospital, ver, BC University of Toronto, Toronto, Ont. We wish to compare the outcomes of 2 perineal operations for The purpose of this study was to evaluate the safety and effi- rectal prolapse: rectal mucosectomy (Delorme’s operation) cacy of artificial bowel sphincter (ABS) implantation in the and perineal rectosigmoidectomy (Altemeier’s operation). management of severe fecal incontinence (FI). We reviewed all 34 patients who had a perineal repair of Ten patients (6 males), with a mean age of 40.6 years, un- rectal prolapse at our hospital from July 1997 to June 2000.
    [Show full text]
  • Efficacy and Safety of a Novel Personalized Navigation Template in Proximal Femoral Corrective Osteotomy for the Treatment of DDH Qiang Shi1,2 and Deyi Sun1*
    Shi and Sun Journal of Orthopaedic Surgery and Research (2020) 15:317 https://doi.org/10.1186/s13018-020-01843-y RESEARCH ARTICLE Open Access Efficacy and safety of a novel personalized navigation template in proximal femoral corrective osteotomy for the treatment of DDH Qiang Shi1,2 and Deyi Sun1* Abstract Background: This present study is aimed to retrospectively evaluate the efficacy and safety of a novel personalized navigation template in proximal femoral corrective osteotomy for the treatment of DDH. Methods: Twenty-nine consecutive patients with DDH who underwent proximal femoral corrective osteotomy were evaluated between August 2013 and June 2017. Based on the different surgical methods, they were divided into the conventional group (n = 14) and navigation template group (n = 15). The osteotomy degrees, radiation exposure, and operation time were compared between the two groups. Results: No major complications relating to osteotomy surgery such as redislocation or avascular necrosis occurred in the navigation template group, which had more accurate osteotomy degrees, less radiation exposure, and shorter operation time when compared with the conventional group (P < 0.05). Moreover, there was significant difference according to the McKay criteria between the two groups (P = 0.0362). Conclusions: The novel personalized navigation template in proximal femoral corrective osteotomy is effective and safe, which could improve the femoral osteotomy accuracy, reduce radiation exposure, and shorten operation time. Keywords: Femoral corrective osteotomy, 3D printing, Navigation template, Developmental dysplasia of the hip Background [3–5]. The performance and positioning of femoral oste- Developmental dysplasia of the hip (DDH) is considered otomy is one of the most important surgical procedures one of the most common three-dimensional (3D) hip to ensure ideal correction effects, but the conventional deformities in children [1].
    [Show full text]
  • Microperforated Hymen Presenting Spontaneous Pregnancy with Cesarean Delivery and Hymenotomy Surgery: a Case Report
    ID Design Press, Skopje, Republic of Macedonia Open Access Macedonian Journal of Medical Sciences. 2018 Mar 15; 6(3):528-530. https://doi.org/10.3889/oamjms.2018.123 eISSN: 1857-9655 Case Report Microperforated Hymen Presenting Spontaneous Pregnancy with Cesarean Delivery and Hymenotomy Surgery: A Case Report Brikene Elshani1, Heroid Arifi1, Armond Daci2* 1Department of Obstetrics and Gynecology, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo; 2Department of Pharmacy, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo Abstract Citation: Elshani B, Arifi H, Daci A. Microperforated BACKGROUND: Female genital tract anomalies including imperforate hymen affect sexual life and fertility. Hymen Presenting Spontaneous Pregnancy with Cesarean Delivery and Hymenotomy Surgery: A Case Report. Open Access Maced J Med Sci. 2018 Mar 15; CASE PRESENTATION: In the present case, we describe a pregnant woman diagnosed with imperforate hymen 6(3):528-530. https://doi.org/10.3889/oamjms.2018.123 which never had penetrative vaginal sex. A 27–year-old married patient with 2 months of amenorrhea presented Keywords: Cesarean Delivery; Imperforate Hymen; in a clinic without any other complications. Her history of difficult intercourse and prolonged menstrual flow were Hymen Incision Surgery reported, and subsequent vaginal examination confirmed the diagnosis of imperforate hymen even though she *Correspondence: Armond Daci. Department of claims to made pinhole surgery in hymen during puberty. Her urine pregnancy test was positive, and an Pharmacy, Faculty of Medicine, University of Prishtina, ultrasound examination revealed 8.3 weeks pregnant. The pregnancy was followed up to 39.5 weeks when she Prishtina, Kosovo. E-mail: [email protected] entered in cesarean delivery in urgency.
    [Show full text]
  • MISSED? Metastatic Spinal Cord Compression NA Quraishi, C Esler ∗ BMJ 342 (7805), 1023-1025
    PUBLICATIONS (ABSTRACTS EXCLUDED) 2014: Metastatic spinal cord compression as a result of the unknown primary tumour. Quraishi NA, Ramoutar D, Sureshkumar D, Manoharan SR, Spencer A, Arealis G, Edwards KL, Boszczyk BM. Eur Spine J. 2014 Apr 2. Trans-oral approach for the management of a C2 neuroblastoma. Salem KM, Visser J, Quraishi NA. Eur Spine J. 2014 Feb 19. Calcified giant thoracic disc herniations: considerations and treatment strategies. Quraishi NA, Khurana A, Tsegaye MM, Boszczyk BM, Mehdian SM. Eur Spine J. 2014 Apr;23 Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival. Varga PP, Szövérfi Z, Fisher CG, Boriani S, Gokaslan ZL, Dekutoski MB, Chou D, Qurais NA, Reynolds JJ, Luzzati A, Williams R, Fehlings MG, Germscheid NM, Lazary A, Rhines LD. Eur Spine J. 2014 Dec 23. Expert's comment concerning Grand Rounds case entitled: "trans-oral approach for the management of a C2 neuroblastoma. (K. M. I. Salem, J. Visser, and N. A. Quraishi).Choi D. Eur Spine J. 2015 Jan;24(1):177-9. Diagnosis and treatment of a rectal-cutaneous fistula: a rare complication of coccygectomy. Behrbalk E, Uri O, Maxwell-Armstrong C, Quraishi NA. Eur Spine J. 2014 Nov 1. A cohort study to evaluate cardiovascular risk of selective and nonselective cyclooxygenase inhibitors (COX-Is) in arthritic patients attending orthopedic department of a tertiary care hospital. Bhosale UA, Quraishi N, Yegnanarayan R, Devasthale D. Niger Med J. 2014 Sep;55(5):417-22. An evidence-based medicine model for rare and often neglected neoplastic conditions. Fisher CG, Goldschlager T, Boriani S, Varga PP, Rhines LD, Fehlings MG, Luzzati A, Dekutoski MB, Reynolds JJ, Chou D, Berven SH, Williams RP, Quraishi NA, Bettegowda C, Gokaslan ZL.
    [Show full text]